Sun Pharmaceutical Industries Limited (BOM:524715)
India
· Delayed Price · Currency is INR 1,643.05
-26.65 (-1.60%)
At close: Feb 21, 2025
BOM:524715 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,943,907 | 3,888,242 | 2,358,729 | 2,194,737 | 1,434,322 | 845,286 | Upgrade
|
| Market Cap Growth | 49.78% | 64.84% | 7.47% | 53.02% | 69.68% | -26.43% | Upgrade
|
| Enterprise Value | 3,771,052 | 3,792,904 | 2,296,495 | 2,136,376 | 1,424,670 | 852,641 | Upgrade
|
| Last Close Price | 1643.05 | 1605.71 | 965.19 | 888.52 | 574.37 | 334.94 | Upgrade
|
| PE Ratio | 34.49 | 40.60 | 27.84 | 67.06 | 49.39 | 22.45 | Upgrade
|
| PS Ratio | 8.77 | 8.02 | 5.37 | 5.68 | 4.28 | 2.57 | Upgrade
|
| PB Ratio | 6.52 | 5.79 | 3.98 | 4.30 | 2.90 | 1.72 | Upgrade
|
| P/TBV Ratio | 8.89 | 8.38 | 6.16 | 6.23 | 4.16 | 2.61 | Upgrade
|
| P/FCF Ratio | - | 39.14 | 82.08 | 29.30 | 28.69 | 16.86 | Upgrade
|
| P/OCF Ratio | - | 32.04 | 47.56 | 24.43 | 23.25 | 12.90 | Upgrade
|
| EV/Sales Ratio | 7.31 | 7.82 | 5.23 | 5.53 | 4.25 | 2.60 | Upgrade
|
| EV/EBITDA Ratio | 25.54 | 29.46 | 19.71 | 21.04 | 17.07 | 12.44 | Upgrade
|
| EV/EBIT Ratio | 30.75 | 36.05 | 24.68 | 26.19 | 22.16 | 17.23 | Upgrade
|
| EV/FCF Ratio | - | 38.18 | 79.91 | 28.52 | 28.49 | 17.01 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.05 | 0.12 | 0.03 | 0.08 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 0.17 | 0.25 | 0.58 | 0.13 | 0.46 | 1.20 | Upgrade
|
| Debt / FCF Ratio | - | 0.33 | 2.40 | 0.17 | 0.77 | 1.66 | Upgrade
|
| Asset Turnover | - | 0.58 | 0.58 | 0.56 | 0.49 | 0.49 | Upgrade
|
| Inventory Turnover | - | 1.08 | 1.12 | 1.17 | 1.05 | 1.17 | Upgrade
|
| Quick Ratio | - | 1.82 | 1.36 | 1.37 | 1.20 | 1.36 | Upgrade
|
| Current Ratio | - | 2.56 | 2.00 | 2.03 | 1.89 | 2.02 | Upgrade
|
| Return on Equity (ROE) | - | 15.20% | 15.42% | 6.74% | 4.61% | 8.89% | Upgrade
|
| Return on Assets (ROA) | - | 7.91% | 7.73% | 7.42% | 5.91% | 4.65% | Upgrade
|
| Return on Capital (ROIC) | 11.20% | 9.63% | 9.81% | 9.64% | 7.25% | 5.49% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.36% | 15.30% | 15.51% | 12.48% | 9.42% | Upgrade
|
| Earnings Yield | 2.90% | 2.46% | 3.59% | 1.49% | 2.02% | 4.45% | Upgrade
|
| FCF Yield | 2.55% | 1.22% | 3.41% | 3.49% | 5.93% | Upgrade
| |
| Dividend Yield | 0.93% | 0.84% | 1.19% | 1.13% | 1.31% | 1.19% | Upgrade
|
| Payout Ratio | 0.00% | 30.26% | 29.73% | 65.97% | 53.70% | 36.63% | Upgrade
|
| Buyback Yield / Dilution | 0.15% | - | - | - | - | -0.00% | Upgrade
|
| Total Shareholder Return | 1.08% | 0.84% | 1.19% | 1.13% | 1.31% | 1.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.